Q4 2015

Source filing unavailable

Q4 2015 · —

Revenue

$12.38M

no prior Q4 2014 on file

Net Income

-$32.93M

no prior Q4 2014 on file

EPS Diluted

-$0.39

no prior Q4 2014 on file

Gross Profit$6,079,000—

Operating Income-$30,606,000—

Operating Cash Flowderived

Same quarter

Metric	Q4 2015	Q4 2014derived from reported figures
Revenue	$12.38M	—
Net Income	-$32.93M	—
EPS Diluted	-$0.39	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NovoCure Ltd · CIK 1645113 · Engraved from SEC EDGAR